Image by neofedex via FlickrGlaxoSmithKline Plc (GSK.L) has settled more lawsuits alleging its Avandia diabetes drug caused heart attacks, heading off the first trial in the United States concerning the medicine.
The company said on Tuesday that terms of the settlement remained confidential. It declined to specify how many claimants were involved.
"We can confirm that the case that was scheduled for the first trial in state court in Philadelphia, for June 1, 2010, has been settled," company spokeswoman Claire Brough said in an emailed statement.
"The next case scheduled for trial is in that court and is scheduled for October 2010. GSK has not settled the multi-district litigation pending in federal court."
The latest move follows reports by plaintiff lawyers last month that about 700 cases had been settled for around $60 million.